Nacuity Pharmaceuticals

Recent Finacing

Series B

Recent Raise

$16.5M

Nacuity Pharmaceuticals, a clinical-stage biopharmaceutical based in Fort Worth, develops antioxidant therapies for oxidative-stress ocular diseases and runs Phase 1/2 trials of oral NPI-001 and intravitreal NPI-002.

Founded 2016

Texas, United States

11-50

Private

nacuity.com

Highlights

Focus Areas

Health Care

Pharmaceutical

Recent Investors

Financials

$16.5M

Total Raised

1

Funding round

1

Investor

Team

Upgrade to view the team

See the team members at Nacuity Pharmaceuticals.